Discover 3,033 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,033
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Santa Monica CA, Los Angeles CA, Duarte CA, Upland CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for
Non-small Cell Lung Cancer,
Location: Santa Monica CA, Duarte CA, Newport Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05877599
Phase1, Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Santa Monica CA, San Diego CA, San Antonio TX, Omaha NE,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05536141
Phase1, Recruiting
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: Santa Monica CA, Los Angeles CA, Las Vegas NV,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05914116
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Los Angeles CA, Dallas TX, Houston TX, Columbus OH,
Sponsor: OncoNano Medicine, Inc.
Sex: All
Age: 18+
Code: NCT06022029
Phase1, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Santa Monica CA, Santa Rosa CA, Albuquerque NM,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05123482
Phase1, Phase2, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Los Angeles CA, Murrieta CA, Glendale CA, Duarte CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
for
Pancreatic Cancer
Location: Los Angeles CA
Sponsor: Anova Innovation Limited
Sex: All
Age: 18+
Code: NCT07444541
Phase1, Phase2, Recruiting
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer
Location: Santa Monica CA, Atlanta GA, Fairfax VA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07098338
Phase2, Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Los Angeles CA, Fountain Valley CA, Santa Rosa CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase3, Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Santa Monica CA, Los Angeles CA, Los Alamitos CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase3, Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
for
HER2-positive Advanced Solid Tumor
Location: Los Angeles CA, Cerritos CA, San Diego CA, Las Vegas NV,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05150691
Phase1, Phase2, Recruiting
LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
for
Advanced Soft-tissue Sarcoma
Location: Santa Monica CA
Sponsor: ERLINDA M GORDON
Sex: All
Age: 18 - 70+
Code: NCT05876715
Phase1, Phase2, Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer